MedPath

FONDAZIONE POLICLINICO UNIVERSITARIO CAMPUS BIO-MEDICO

🇮🇹Italy
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

25

Active:3
Completed:4

Trial Phases

3 Phases

Phase 2:2
Phase 4:2
Not Applicable:14

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (18 trials with phase data)• Click on a phase to view related trials

Not Applicable
14 (77.8%)
Phase 2
2 (11.1%)
Phase 4
2 (11.1%)

OM 85 to Prevent Respiratory Infections in Older At Risk Patients

Not Applicable
Active, not recruiting
Conditions
Respiratory Tract Infections (RTI)
Interventions
First Posted Date
2025-09-17
Last Posted Date
2025-09-17
Lead Sponsor
Fondazione Policlinico Universitario Campus Bio-Medico
Target Recruit Count
360
Registration Number
NCT07178002
Locations
🇮🇹

Fondazione Policlinico Universitario Campus Bio Medico, Roma, Italia, Italy

Low Impact Laparoscopy In Bariatric Surgery

Not Applicable
Recruiting
Conditions
Obesity, Morbid
First Posted Date
2025-08-13
Last Posted Date
2025-09-16
Lead Sponsor
Fondazione Policlinico Universitario Campus Bio-Medico
Target Recruit Count
128
Registration Number
NCT07119437
Locations
🇮🇹

Policlinico Campus Bio-Medico, Rome, Italy, Italy

Improving the Perception of Stress and Mutuality in Caregivers (MI-DEAR Study) of Migraine Patients With Depressive Symptoms Treated With Fremanezumab: A Study to Evaluate Whether Fremanezumab Reduces the Impact on Caregivers and Increases Couple Reciprocity

Recruiting
Conditions
Migraine
Interventions
First Posted Date
2025-06-19
Last Posted Date
2025-06-19
Lead Sponsor
Fondazione Policlinico Universitario Campus Bio-Medico
Target Recruit Count
300
Registration Number
NCT07029126
Locations
🇮🇹

Ospedali Riuniti "Umberto I"- GM LANCISI G.SALESI, Ancona, Italy

🇮🇹

PO Avezzano "S.Filippo e Nicola", Avezzano, Italy

🇮🇹

Clinica Neurologica "L. Amaducci" Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari, Bari, Italy

and more 7 locations

Dose Escalated Concomitant Boost Radiotherapy for Early Breast Cancer

Not Applicable
Recruiting
Conditions
Breast Cancer
First Posted Date
2025-06-15
Last Posted Date
2025-06-15
Lead Sponsor
Fondazione Policlinico Universitario Campus Bio-Medico
Target Recruit Count
132
Registration Number
NCT07021846
Locations
🇮🇹

Università Campus Biomedico, Roma, Italy

Concomitant Radiotherapy and New Drugs in Metastatic Breast Cancer

Recruiting
Conditions
Breast Cancer
Radiotherapy; Complications
First Posted Date
2025-06-15
Last Posted Date
2025-06-15
Lead Sponsor
Fondazione Policlinico Universitario Campus Bio-Medico
Target Recruit Count
300
Registration Number
NCT07021911
Locations
🇮🇹

Radiation Oncology Department Fondazione Policlinico Campus BioMedico, Rome, Italy

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.